Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Vitile XL 30mg tablets
0601021M0BJAAAM
|
Vitile | Gliclazide | Endocrine System | No data available |
|
Vivazide 80mg tablets
0601021M0BDAAAA
|
Vivazide | Gliclazide | Endocrine System | No data available |
|
WP Thyroid 65mg (1 grain) tablets
0602010Z0BCAAAB
|
WP Thyroid | Levothyroxine sodium and liothyronine | Endocrine System | No data available |
|
Xywin 30mg modified-release tablets
0601021M0BRAAAM
|
Xywin | Gliclazide | Endocrine System | No data available |
|
Yselty 100mg tablets
0607020Y0BBAAAB
|
Yselty | Linzagolix | Endocrine System | No data available |
|
Yselty 200mg tablets
0607020Y0BBABAC
|
Yselty | Linzagolix | Endocrine System | No data available |
|
Zepron 500microgram capsules
0604020B0BCAAAA
|
Zepron | Dutasteride | Endocrine System | No data available |
|
Zerlinda 4mg/100ml infusion bags
0606020V0BDAAAD
|
Zerlinda | Zoledronic acid | Endocrine System | No data available |
|
Zoledronic acid 4mg inf vials
0606020V0AAAAAA
|
Zoledronic acid | Zoledronic acid | Endocrine System | No data available |
|
Zoledronic acid 5mg/100ml infusion bags
0606020V0AAAGAG
|
Zoledronic acid | Zoledronic acid | Endocrine System | No data available |
|
Zometa 4mg inf vials
0606020V0BBAAAA
|
Zometa | Zoledronic acid | Endocrine System | No data available |
|
Zometa 4mg/100ml solution for infusion bottles
0606020V0BBACAD
|
Zometa | Zoledronic acid | Endocrine System | No data available |
|
Zometa 4mg/5ml solution for infusion vials
0606020V0BBABAB
|
Zometa | Zoledronic acid | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.